Compared with controls, CKD subjects were more likely to receive activated vitamin D, angiotensin converting enzyme inhibitors (ACEi) and to have co-morbidities including diabetes mellitus, hypertension, CVD and hyperlipidemia. The gene discussed is ACE; the disease is hyperlipidemia.